4-Fluorotranylcypromine is a chemical compound that belongs to the class of monoamine oxidase inhibitors (MAOIs), which are primarily used in the treatment of depression and anxiety disorders. Its structure features a fluorine atom substituted at the para position of the tranylcypromine backbone, which enhances its pharmacological properties. The compound exhibits a mechanism of action that involves the inhibition of monoamine oxidase enzymes, leading to increased levels of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. This action can contribute to its antidepressant effects. 4-Fluorotranylcypromine is characterized by its relatively high lipophilicity, which may influence its absorption and distribution in biological systems. Additionally, it may have a unique side effect profile compared to other MAOIs, necessitating careful monitoring for potential interactions with dietary tyramine and other medications. As with any pharmacological agent, its use should be guided by a healthcare professional, considering the balance between therapeutic benefits and potential risks.

4-fluorotranylcypromine

113516-71-5: 4-Fluorotranylcypromine is a chemical compound that belongs to the class of monoamine oxidase inhibitors (MAOIs), which are primarily used in the treatment of depression and anxiety disorders. Its structure features a fluorine atom substituted at the para position of the tranylcypromine backbone, which enhances its pharmacological properties. The compound exhibits a mechanism of action that involves the inhibition of monoamine oxidase enzymes, leading to increased levels of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. This action can contribute to its antidepressant effects. 4-Fluorotranylcypromine is characterized by its relatively high lipophilicity, which may influence its absorption and distribution in biological systems. Additionally, it may have a unique side effect profile compared to other MAOIs, necessitating careful monitoring for potential interactions with dietary tyramine and other medications. As with any pharmacological agent, its use should be guided by a healthcare professional, considering the balance between therapeutic benefits and potential risks.

CAS 113516-71-5

4-fluorotranylcypromine

rac-(1R,2S)-2-(4-fluorophenyl)cyclopropan-1-amine

Ref: IN-DA0008UZ